Page last updated: 2024-08-24

telmisartan and Hypotension

telmisartan has been researched along with Hypotension in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's3 (27.27)29.6817
2010's5 (45.45)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Cheng, YQ; Guo, PY; Liu, AJ; Shi, WT; Xia, T; Xu, LL1
Fujisawa, T; Hojo, T; Kimura, Y; Otsuka, Y; Shibuya, M1
Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S1
Justin, A; Ramanathan, M; Sathishkumar, M; Shanthakumari, S; Sudheer, A1
Chen, CH; Cheng, HM; Hoshide, S; Huang, QF; Kario, K; Park, CG; Park, S; Wang, JG1
Bangalore, S; Messerli, FH; Ram, VS1
Düsing, R; Nitschmann, S1
Anderson, C; Copland, I; Dagenais, G; Dyal, L; Pogue, J; Schumacher, H; Sleight, P; Teo, K; Yusuf, S1
Alonso, I; Ayala, DE; Fernández, JR; Fontao, MJ; Hermida, RC; Mojón, A1
Böhm, M; Fagard, R; Gao, P; Mancia, G; Pogue, J; Redon, J; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Weber, M; Williams, B; Yusoff, K; Yusuf, S1
Heinemann, A; Holzer, P; Jocic, M; Sattler, V; Wienen, W1

Reviews

2 review(s) available for telmisartan and Hypotension

ArticleYear
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Lancet (London, England), 2017, Jun-03, Volume: 389, Issue:10085

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Hypertension; Hypotension; Male; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Telmisartan

2017
Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Yonsei medical journal, 2016, Volume: 57, Issue:6

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Reference Values; Risk Factors; Stroke; Telmisartan

2016

Trials

2 trial(s) available for telmisartan and Hypotension

ArticleYear
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
    Lancet (London, England), 2008, Sep-27, Volume: 372, Issue:9644

    Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cough; Female; Follow-Up Studies; Humans; Hypotension; Kaplan-Meier Estimate; Male; Risk Reduction Behavior; Single-Blind Method; Telmisartan; Therapeutic Equivalency

2008
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).
    Journal of the American College of Cardiology, 2012, Jan-03, Volume: 59, Issue:1

    Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure Determination; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Ramipril; Reference Values; Risk Assessment; Survival Rate; Telmisartan; Treatment Outcome

2012

Other Studies

7 other study(ies) available for telmisartan and Hypotension

ArticleYear
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo.
    Pharmacology research & perspectives, 2023, Volume: 11, Issue:2

    Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Hypotension; Rats; Rats, Inbred SHR; Telmisartan

2023
Refractory Hypotension During General Anesthesia Despite Withholding Telmisartan.
    Anesthesia progress, 2020, 06-01, Volume: 67, Issue:2

    Topics: Anesthesia, General; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypotension; Telmisartan

2020
Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 122

    Topics: Animals; Benzimidazoles; Benzoates; Brain; Brain Ischemia; Cytokines; Drug Synergism; Drug Therapy, Combination; Hypotension; Male; Neuroprotective Agents; Nimodipine; Rats; Rats, Sprague-Dawley; Telmisartan

2014
Telmisartan, ramipril, or both in patients at high risk of vascular events.
    The New England journal of medicine, 2008, Jul-24, Volume: 359, Issue:4

    Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypotension; Ramipril; Telmisartan

2008
[ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ].
    Der Internist, 2008, Volume: 49, Issue:9

    Topics: Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypotension; Ramipril; Risk Assessment; Risk Factors; Telmisartan

2008
Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
    Chronobiology international, 2010, Volume: 27, Issue:3

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Enalapril; Female; Half-Life; Humans; Hypertension; Hypotension; Male; Middle Aged; Receptors, Angiotensin; Renin-Angiotensin System; Risk; Telmisartan

2010
Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Diffusion; Female; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Heart Rate; Hypotension; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Telmisartan; Vasoconstrictor Agents

1999